An acid-relief agent comprising a fermented vegetable extract obtained from a mixture of banana leaves, sweet potato roots, potato skin, seaweed, grape leaves, tendrils leaves, fig roots, emperor bean roots, and deep sea water; and nanocalcium mineral powder obtained from the thermal decomposition and grinding of a mixture of mica ore, mother of pearl, oyster shells. and oyster bay.

An acid-relief agent comprising a fermented vegetable extract obtained from a mixture of banana leaves, sweet potato roots, potato skin, seaweed, grape leaves, tendrils leaves, fig roots, emperor bean roots, and deep sea water; and nanocalcium mineral powder obtained from the thermal decomposition and grinding of a mixture of mica ore, mother of pearl, oyster shells. and oyster bay.

An acid-relief agent comprising a fermented vegetable extract obtained from a mixture of banana leaves, sweet potato roots, potato skin, seaweed, grape leaves, tendrils leaves, fig roots, emperor bean roots, and deep sea water; and nanocalcium mineral powder obtained from the thermal decomposition and grinding of a mixture of mica ore, mother of pearl, oyster shells. and oyster bay.

The invention relates to compositions comprising fatty acid mixtures comprising very long chain unsaturated fatty acids. The fatty acids of the fatty acid mixture are isolated from natural oils. Particularly, the fatty acid mixtures comprise an enriched amount of both very long chain monounsaturated fatty acids (VLCMUFAs) and very long chain polyunsaturated fatty acids (VLCPUFAs). In one embodiment of the invention, the amount of cholesterol in the fatty acid mixture is minimised and a method for production is provided.

The present invention relates to a composition comprising: (i) from 10 to 40% by weight, preferably from 20 to 30% by weight of an edible oil; (ii) lactose and (iii) mannitol

wherein the edible oil comprises at least 20% by weight, preferably between 25 and 40% by weight, typically 30 and 35% by weight of polyunsaturated fatty acids and the weight ratio of lactose to mannitol is from 1:3 to 3:1, preferably between 1:2 to 2:1, more preferably 1:1.

The present invention relates to a composition comprising: (i) from 10 to 40% by weight, preferably from 20 to 30% by weight of an edible oil; (ii) lactose and (iii) mannitol

wherein the edible oil comprises at least 20% by weight, preferably between 25 and 40% by weight, typically 30 and 35% by weight of polyunsaturated fatty acids and the weight ratio of lactose to mannitol is from 1:3 to 3:1, preferably between 1:2 to 2:1, more preferably 1:1.

The invention relates to inhibitors of monoamine oxidase type B (iMAO-B) for use in the treatment of pathologies or disorders associated with inflammasome activation, pharmaceutical compositions comprising said inhibitors for use thereof, medical devices comprising such compositions, and therapeutic methods for treatment of pathologies or disorders associated with inflammasome activation by administration of inhibitors of the monoamine oxidase type B enzyme.

The invention relates to inhibitors of monoamine oxidase type B (iMAO-B) for use in the treatment of pathologies or disorders associated with inflammasome activation, pharmaceutical compositions comprising said inhibitors for use thereof, medical devices comprising such compositions, and therapeutic methods for treatment of pathologies or disorders associated with inflammasome activation by administration of inhibitors of the monoamine oxidase type B enzyme.

The invention relates to devices and compositions useful for and methods of female genital skin reduction, improvement of skin tone and treatment of female urinary incontinence, as well as the treatment or improvement of other clinical conditions, including but not limited to those involving the female genitalia.

The invention relates to devices and compositions useful for and methods of female genital skin reduction, improvement of skin tone and treatment of female urinary incontinence, as well as the treatment or improvement of other clinical conditions, including but not limited to those involving the female genitalia.